Granules India gets FDA approval for generic epilepsy drug Levetiracetam

Granules India gets FDA approval for generic epilepsy drug Levetiracetam

Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets USP, in 250 mg, 500 mg, 750 mg, and 1,000 mg strengths. The drug, bioequivalent and therapeutically equivalent to UCB, Inc.’s reference listed drug (RLD), Keppra Tablets, is used […]

Zydus Lifesciences subsidiary launches Trokendi XR generic in US

Zydus Lifesciences subsidiary launches Trokendi XR generic in US

Zydus Lifesciences (previously Cadila Healthcare) said that its subsidiary Zydus Pharmaceuticals (USA) Inc. has launched Topiramate Extended-Release Capsules in the US. The launch follows the final approval received by Zydus Pharmaceuticals (USA) from the US Food and Drug Administration (FDA) for marketing Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg. The approved […]

MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products

MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products

MGC Pharmaceuticals, a developer of phytocannabinoid-derived medicines, has signed a $24 million supply and distribution deal with US-based AMC Holdings. The deal is for the supply of the company’s products, which include epilepsy candidate CannEpil, dementia and Alzheimer’s candidate CogniCann, and CimetrA over an initial three-year period. MGC Pharmaceuticals said that this is its maiden […]

Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal

Jazz Pharmaceuticals to acquire GW Pharmaceuticals in $7.2bn deal

In a significant move within the pharmaceutical industry, Irish biopharma company Jazz Pharmaceuticals has announced an agreement to acquire British-based GW Pharmaceuticals in a monumental $7.2 billion cash-and-stock transaction. This acquisition is set to create a powerhouse in the neuroscience field with a robust global commercial and operational footprint. Strategic Acquisition to Enhance Neuroscience Portfolio […]